Home>Topics>Finance>Bill Ackman

Bill Ackman

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. MOVES-Pershing Square Capital hires Stephen Fraidin as vice chairman - WSJ

    Headlines

    Tue, 20 Jan 2015

    Jan 20 (Reuters) - Activist hedge fund manager William Ackman 's Pershing Square Capital Holdings is hiring mergers and acquisitions lawyer Stephen Fraidin as vice chairman, the Wall Street Journal...

  2. Billionaire investor renews Herbalife attack with share collapse prediction

    Headlines

    Tue, 13 Jan 2015

    CHICAGO, Jan 13 (Reuters) - Two years after first accusing the U.S.'s Herbalife Ltd of fraud, billionaire investor William Ackman reiterated on Monday that he expects the nutrition company's stock price to collapse to zero and said it would happen within a year.

  3. Leading JC Penney Back to Growth

    Headlines

    Mon, 12 Jan 2015

    Activist Investors One element of the upheaval at Penney’s has been the intrusion of activist investors—in the form of Bill Ackman from the hedge fund Pershing Square and Steven Roth of Vornado Real Estate. The two worked their way onto the JC Penney board

  4. U.S. hedge fund manager Ackman makes $10 mln charity donation

    Headlines

    Fri, 9 Jan 2015

    BOSTON, Jan 9 (Reuters) - William Ackman is putting his money where his mouth is.

  5. Actavis Beats Out Valeant’s Hostile Bid for Wide-Moat Allergan

    Commentary

    Mon, 17 Nov 2014

    for Allergan. We don’t anticipate Actavis’ $219 offer will spur a bidding war with Valeant and its partnership with Bill Ackman ’s Pershing Square, which was previously pursuing a hostile takeover with a last official bid near $180. Although we

  6. We're Skeptical of a Potential Zoetis Sale Despite Pershing Square's Reported 10% Stake

    Commentary

    Tue, 11 Nov 2014

    Activist investor William Ackman 's Pershing Square Capital Management has acquired a roughly 10% stake in Zoetis and will attempt to force the company to sell

  7. Allergan Sustains Strong Performance as Special Board Meeting Approaches

    Commentary

    Mon, 27 Oct 2014

    management focuses on an aggressive earnings growth plan to help avoid the takeover challenge from Valeant Pharmaceuticals and Bill Ackman ’s Pershing Square. We’re leaving our $185 fair value estimate unchanged despite a few minor adjustments to our model

  8. UPDATE 2-U.S. court orders Allergan to produce board documents

    Headlines

    Mon, 22 Sep 2014

    Sept 22 (Reuters) - A U.S. court ordered drugmaker Allergan Inc to produce board documents related to its strategy to counter a hostile bid by William Ackman 's Pershing Square Capital Management and...

  9. U.S. court orders Allergan to produce board documents

    Headlines

    Mon, 22 Sep 2014

    Sept 22 (Reuters) - A U.S. court ordered drugmaker Allergan Inc to produce board documents related to its strategy to counter the hostile bid by William Ackman 's Pershing Square Capital Management...

  10. UPDATE 1-Ackman's Pershing Square plans $2 bln Amsterdam fund listing

    Headlines

    Mon, 15 Sep 2014

    AMSTERDAM/LONDON, Sept 15 (Reuters) - Pershing Square Holdings, a fund managed by activist investor Bill Ackman , hopes to raise $2 billion from a listing on the Euronext Amsterdam stock exchange, the...

« Prev12345Next »
Content Partners